1. Home
  2. CTMX vs CDRO Comparison

CTMX vs CDRO Comparison

Compare CTMX & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CDRO
  • Stock Information
  • Founded
  • CTMX 2008
  • CDRO 2014
  • Country
  • CTMX United States
  • CDRO Luxembourg
  • Employees
  • CTMX N/A
  • CDRO N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CDRO Services-Misc. Amusement & Recreation
  • Sector
  • CTMX Health Care
  • CDRO Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • CDRO Nasdaq
  • Market Cap
  • CTMX 380.9M
  • CDRO 382.0M
  • IPO Year
  • CTMX 2015
  • CDRO N/A
  • Fundamental
  • Price
  • CTMX $1.91
  • CDRO $8.07
  • Analyst Decision
  • CTMX Strong Buy
  • CDRO Strong Buy
  • Analyst Count
  • CTMX 3
  • CDRO 1
  • Target Price
  • CTMX $5.67
  • CDRO $10.00
  • AVG Volume (30 Days)
  • CTMX 3.1M
  • CDRO 23.1K
  • Earning Date
  • CTMX 08-07-2025
  • CDRO 07-31-2025
  • Dividend Yield
  • CTMX N/A
  • CDRO N/A
  • EPS Growth
  • CTMX 263.20
  • CDRO N/A
  • EPS
  • CTMX 0.49
  • CDRO 0.08
  • Revenue
  • CTMX $141,100,000.00
  • CDRO $207,789,626.00
  • Revenue This Year
  • CTMX N/A
  • CDRO $13.97
  • Revenue Next Year
  • CTMX N/A
  • CDRO $8.37
  • P/E Ratio
  • CTMX $3.91
  • CDRO $97.44
  • Revenue Growth
  • CTMX 18.01
  • CDRO 24.16
  • 52 Week Low
  • CTMX $0.40
  • CDRO $5.75
  • 52 Week High
  • CTMX $3.10
  • CDRO $8.76
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 39.81
  • CDRO 43.11
  • Support Level
  • CTMX $1.72
  • CDRO $8.04
  • Resistance Level
  • CTMX $2.43
  • CDRO $8.28
  • Average True Range (ATR)
  • CTMX 0.20
  • CDRO 0.33
  • MACD
  • CTMX -0.06
  • CDRO -0.05
  • Stochastic Oscillator
  • CTMX 26.84
  • CDRO 25.64

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CDRO Codere Online Luxembourg S.A.

Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.

Share on Social Networks: